Eyewitness accounts and videos taken from across the Midwest reveal a large fireball streak across the daytime sky ...
Accurately measuring small shifts in biological markers, like proteins and neurotransmitters, or harmful chemicals in the ...
Chronos‑PD shows that biological changes associated with Parkinson’s disease (PD) can emerge up to 12 years before clinical diagnosisUncovered reproducible early molecular signals and distinct ...
Despite decades of advancements in surgical techniques, chemotherapy, and radiotherapy, the clinical outlook for patients diagnosed with primary brain tumors remains sobering. Whi ...
A newly identified molecular player may help explain how cartilage in the jaw joint resists inflammatory damage.
Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced an upcoming ...
Northwestern Medicine scientists have discovered that specialized immune cells within the glioblastoma tumor metabolize ...
Partnership supports expanded biomarker discovery efforts within MJFF's Parkinson's Progression Markers Initiative ...
Mestag Therapeutics (“Mestag”), a biotech company harnessing fibroblast immunology to develop impactful treatments for ...
A London-based biotech start-up is accelerating its growth after securing investment to advance artificial intelligence-driven drug discovery technology. Ternary Therapeutics has… | Health | London | ...
Why do some people live much longer than others? This question has puzzled scientists for many years. While factors such as ...
10hon MSN
The E-Nose knows: AI learns to smell
Among the possible implications are restoring a sense of smell, and sniffing out potential health concerns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results